2 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 2 | Recruiting 2 |
Follow QLC5508: new trials by email Literature Review of QLC5508 trials Research Report on QLC5508
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer QLC5508, abiraterone acetate, enzalutamide - Advanced Prostate Cancer | Phase 1 / Phase 2 | Recruiting | Qilu Pharmaceutical Co., Ltd. | 212 | 2025-11-05 | 2026-06-02 |
| A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors QLC5508, QL1706, Cisplatin/ Carboplatin - Advanced Solid Tumor | Phase 1 / Phase 2 | Recruiting | Qilu Pharmaceutical Co., Ltd. | 444 | 2025-10-24 | 2025-12-01 |
Qilu Pharmaceutical Co., Ltd. (2)
China (2)